Sundyota Numandis Probioceuticals Private Limited - Company Profile

It is a pharma private limited company based in Ahmedabad, Gujarat, India, established in 2011.

2011 Ahmedabad, Gujarat, India Active

Last Updated: January 06, 2026

About Sundyota Numandis Probioceuticals Private Limited

Sundyota Numandis Probioceuticals Private Limited, a active private limited company, was established on 11 October 2011 in Ahmedabad, Gujarat, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U24230GJ2011PTC067414. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹4.00 Cr and a paid-up capital of ₹2.41 Cr.

It upholds a compliant status. Employing 175 professional, Its leadership includes Bimal Indravadan Trivedi (Director), Ketul Rajendra Shah (Director), Dinesh Kumar Arora (Director). Past directors included Ketul Rajendra Shah, Smita Ravindra Bhatt, Mohit Tamhankar. It holds ₹121.28 Cr open charges and ₹9.83 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 701, Indraprasth Corporate, 100Ft Road Prahladnagar, Ahmedabad, Gujarat, 380015.

Company Details

CIN/LLPIN
U24230GJ2011PTC067414
Registration Number
067414
Incorporation Date
11 October 2011
Authorized Capital
₹4.00 Cr
Paid-Up Capital
₹2.41 Cr
ROC Code
Roc Ahmedabad
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 4.00 Cr as on 06-01-2026
Paid Up Capital ₹ 2.41 Cr as on 06-01-2026
Company Age 14 Year, 4 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 121.28 Cr as on 06-01-2026
Satisfied Charges ₹ 9.83 Cr as on 06-01-2026
Revenue Growth **** 13.82% (FY 2023)
Profit Growth **** 22.54% (FY 2023)
Ebitda **** 27.34% (FY 2023)
Net Worth 25.49% (FY 2023)
Total Assets **** 27.03% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Sundyota Numandis Probioceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Sundyota Numandis Probioceuticals Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Bimal Indravadan Trivedi	Director	11 Oct 2011	Current
Ketul Rajendra Shah	Director	19 Nov 2012	Current
Dinesh Kumar Arora	Director	11 Oct 2011	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	19 Sep 2013	Past
Pramod Abcsdd	Director	28 Mar 2014	Past
Pramod Abcsdd	Director	14 Mar 2015	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sundyota Numandis Probioceuticals.

Sundyota Numandis Probioceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.82% increase. The company also saw a substantial improvement in profitability, with a 22.54% increase in profit. The company's net worth Soared by an impressive increase of 25.49%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

13.82%

*******

Revenue from Operations

*******

15.61%

*******

Total Assets

*******

27.03%

*******

Profit or Loss

*******

22.54%

*******

Net Worth

*******

25.49%

*******

EBITDA

*******

27.34%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sundyota Numandis Probioceuticals?

In 2023, Sundyota Numandis Probioceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹1,212,800,000.00

Satisfied Charges

₹98,300,000.00

Charges Breakdown by Lending Institutions

State Bank Of India : 121.28 Cr

Latest Charge Details

Date	Lender	Amount	Status
22 Feb 2019	State Bank Of India	₹52.50 Cr	Open
25 Jan 2019	State Bank Of India	₹51.62 Cr	Open
25 Jan 2019	State Bank Of India	₹17.16 Cr	Open
19 Feb 2019	Idbi Bank Limited	₹3.30 M	Satisfied
25 May 2015	Idbi Bank Limited	₹9.50 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Sundyota Numandis Probioceuticals?

Sundyota Numandis Probioceuticals has a workforce of 175 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Sundyota Numandis Probioceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sundyota Numandis Probioceuticals's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sundyota Numandis Probioceuticals

Recent Activity within the Organization

Annual General Meeting

Sundyota Numandis Probioceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
30 Sep 2025
Balance Sheet

The activity Sundyota Numandis Probioceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was completed.
31 Mar 2025
Charges

The activity A charge with State Bank Of India of Rs. 52.50 Cr registered on 22 Feb 2019 with Charge ID 100254825 was modified on 20 Nov 2024. was completed.
20 Nov 2024
Charges

A charge with State Bank Of India of Rs. 51.62 Cr registered on 25 Jan 2019 with Charge ID 100246544 was modified on 18 Nov 2024. was recorded as a recent event.
18 Nov 2024
Charges

Progress on A charge with State Bank Of India of Rs. 17.16 Cr registered on 25 Jan 2019 with Charge ID 100246548 was modified on 14 Aug 2024. was documented.
14 Aug 2024
Charges

Progress on A charge registered on 19 Feb 2019 via Charge ID 100245319 with Idbi Bank Limited was fully satisfied on 05 Jul 2021. was documented.
05 Jul 2021

Explore recent activity and updates - View Recent Activity